Gene Expression Analysis Market

The report "Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, Gene Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Data Analysis), Application (Drug discovery & Development, Clinical Diagnostics), End User, and Region - Global Forecast to 2031" The gene expression analysis market is expected to reach USD 5.93 billion in 2031 from USD 4.23 billion in 2026, at a CAGR of 7.0% during the forecast period.

Browse 430 market data Tables and 50 Figures spread through 450 Pages and in-depth TOC on "Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, Gene Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Data Analysis), Application (Drug discovery & Development, Clinical Diagnostics), End User, and Region - Global Forecast to 2031"
View detailed Table of Content here -https://www.marketsandmarkets.com/Market-Reports/gene-expression-analysis-market-156613968.html

The gene expression analysis market is experiencing significant growth, driven by the increasing focus on understanding gene activity in disease development and therapeutic response. Pharmaceutical and biotechnology companies are progressively integrating gene expression approaches into their research workflows to enhance drug development outcomes and support precision medicine strategies. The growing emphasis on biomarker discovery, personalized therapies, and targeted treatment approaches is further accelerating the demand for expression profiling and transcriptomic insights. Moreover, the rising prevalence of chronic diseases, expanding oncology research, and increased focus on rare genetic disorders are contributing to market expansion. However, the market faces challenges such as high operational costs, complexities associated with interpreting large and intricate datasets, and a shortage of skilled professionals, which may hinder its growth trajectory.

By offering, the reagents & consumables segment held the largest share of the gene expression analysis market in 2025.

By offering, the gene expression analysis market is segmented into reagents & consumables, Instruments, and Services. In 2025, reagents & consumables accounted for the largest market share. This is primarily attributed to their recurring usage across gene expression workflows, leading to consistent demand from research laboratories and clinical settings. The growing volume of gene expression studies, coupled with increased research activities in areas such as oncology and genetic disorders, has further driven the consumption of these products. Additionally, the need for high-quality and reliable reagents to ensure accuracy and reproducibility in results contributes to the dominance of this segment.

By application, the drug discovery & development segment held the largest share of the gene expression analysis market in 2025.

By application, the gene expression analysis market is segmented into drug discovery & development, clinical diagnostics, and other applications. In 2025, drug discovery & development accounted for the largest market share. This is due to the increasing reliance on gene expression insights to identify potential drug targets, understand disease mechanisms, and evaluate therapeutic responses. The expanding pipeline of novel therapeutics, particularly in oncology and rare diseases, has significantly increased the adoption of gene expression analysis in early-stage research and development. Furthermore, the growing focus on precision medicine and biomarker-based drug development continues to strengthen the position of this segment in the market.

By region, North America accounted for the largest share of the market in 2025.

In 2025, North America held the largest share of the gene expression analysis market. This is supported by a strong pharmaceutical and biotechnology base, along with rapid adoption of advanced molecular research approaches. The US leads in research funding, innovation, and regulatory support for genomic studies. The presence of leading research institutes, clinical laboratories, and major life sciences companies drives demand for gene expression analysis across various applications. Ongoing research programs, consistent funding, and strong collaboration between industry and academia further support market growth in North America.

Some of the leading players in the market include Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Revvity (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Hoffmann-La Roche Ltd (Switzerland), Bruker (US), and Bio-Rad Laboratories, Inc. (US), among others.

Don’t miss out on business opportunities in Gene Expression Analysis Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]